Emerging paradigms in the renal pathology of viral diseases

Clinical Journal of the American Society of Nephrology

Volumn 2, Issue SUPPL. 1, 2007, Pages

  Alpers, Charles E ^a   Kowalewska, Jolanta ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL; HEPATITIS C; HUMAN; KIDNEY; KIDNEY DISEASE; PATHOLOGY; REVIEW; VIROLOGY; VIRUS INFECTION;

AIDS-ASSOCIATED NEPHROPATHY; ANIMALS; HEPATITIS C; HUMANS; KIDNEY; KIDNEY DISEASES; POLYOMAVIRUS INFECTIONS;

EID: 34748870656     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00280107     Document Type: Review

References (42)

1. Cohen AH, Sun NC, Shapshak P, Imagawa DT: Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy. Mod Pathol 2: 125-128, 1989
2. Kimmel PL, Ferreira-Centeno A, Farkas-Szallasi T, Abraham AA, Garrett CT: Viral DNA in microdissected renal biopsy tissue from HIV infected patients with nephrotic syndrome. Kidney Int 43: 1347-1352, 1993
3. Alpers CE: Light at the end of the TUNEL: HIV-associated thrombotic microangiopathy. Kidney Int 63: 385-396, 2003
4. Bruggeman LA, Ross MD, Tanji N, Cara A, Dikman S, Gordon RE, Burns GC, D'Agati VD, Winston JA, Klotman ME, Klotman PE: Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol 11: 2079-2087, 2000
5. Winston JA, Bruggeman LA, Ross MD, Jacobson J, Ross L, D'Agati VD, Klotman PE, Klotman ME: Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 344: 1979-1984, 2001
6. Marras D, Bruggeman LA, Gao F, Tanji N, Mansukhani MM, Cara A, Ross MD, Gusella GL, Benson G, D'Agati VD, Hahn BH, Klotman ME, Klorman PE: Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med 8: 522-526, 2002
7. Dickie P, Felser J, Eckhaus M, Bryant J, Silver J, Marinos N, Notkins AL: HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 185: 109-119, 1991
8. Bruggeman LA, Dikman S, Meng C, Quaggin SE, Coffman TM, Klotman PE: Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest 100: 84-92, 1997
9. Hanna Z, Kay DG, Rebai N, Guimond A, Jothy S, Jolicoeur P: Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95: 163-175, 1998
10. Kajiyama W, Kopp JB, Marinos NJ, Klotman PE, Dickie P: Glomerulosclerosis and viral gene expression in HIV-transgenic mice: Role of nef. Kidney Int 58: 1148-1159, 2000
11. Husain M, D'Agati VD, He JC, Klotman ME, Klotman PE: HIV-1 Nef induces dedifferentiation of podocytes in vivo: A characteristic feature of HIVAN. AIDS 19: 1975-1980, 2005
12. Zhong J, Zuo Y, Ma J, Fogo AB, Jolicoeur P, Ichikawa I, Matsusaka T: Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. Kidney Int 68: 1048-1060, 2005
13. Barisoni L, Kriz W, Mundel P, D'Agati V: The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 10: 51-61, 1999
14. Shankland SJ, Either F, Hudkins KL, Goodpaster T, D'Agati V, Alpers CE: Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: Role in podocyte proliferation and maturation. Kidney Int 58: 674-683, 2000
15. Peraldi MN, Maslo C, Akposso K, Mougenot B, Rondeau E, Sraer JD: Acute renal failure in the course of HW infection: A single-institution retrospective study of ninety-two patients and sixty renal biopsies. Nephrol Dial Transplant 14: 1578-1585, 1999
16. Randhawa P, Brennan DC: BK virus infection in transplant recipients: An overview and update. Am J Transplant 6: 2000-2005, 2006
17. Bracamonte E, Leca N, Smith KD, Nicosia RF, Nickeleit V, Kendrick E, Furmanczyck F, Davis CL, Alpers CE, Kowalewska J: Tubular basement membrane immune deposits in association with BK polyomavirus nephropathy. Am J Transplant 2007, in press
18. Leca NB, Davis LD, Alpers CE, Kowalewska J: Clinical significance of tubular basement membrane immune deposits in polyoma virus nephropathy [Abstract]. J Am Soc Nephrol 17: 761A, 2006
19. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Couser WG, Corey L, Wener MH, Alpers CE: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328: 465-470, 1993
20. D'Amico G, Fornasieri A: Cryoglobulinemic glomerulonephritis: A membranoproliferative glomerulonephritis induced by hepatitis C virus. Am J Kidney Dis 25: 361-369, 1995
21. Sabry AA, Sobh MA, Irving WL, Grabowska A, Wagner BE, Fox S, Kudesia G, El Hahas AM: A comprehensive study of the association between hepatitis C virus and glomerulopathy. Nephrol Dial Transplant 7: 239-245, 2002
22. Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH: Hepatitis C and renal disease: An update. Am J Kidney Dis 42: 631-657, 2003
23. Roccatello D, Fornasieri A, Giachino O, Rossi D, Beltrame A, Banfi G, Confalonieri R, Tarantino A, Pasquali S, Amoroso A, Savoldi S, Colombo V, Manno C, Ponzetto A, Moriconi L, Pani A, Rustichelli R, DiBelgiojoso GB, Comotti C, Quarenghi MI: Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Am J Kidney Dis 49: 69-82, 2007
24. Johnson RJ, Willson R, Yamabe H, Couser W, Alpers CE, Wener MH, Davis C, Gretch DR: Renal manifestations of hepatitis C virus infection. Kidney Int 46: 1255-1263, 1994
25. Beddhu S, Bastacky S, Johnson JP: The clinical and morphologic spectrum of renal cryoglobulinemia. Medicine (Baltimore) 81: 398-409, 2002
26. D'Amico G, Colasanti G, Ferrario F, Sinico RA: Renal involvement in essential mixed cryoglobulinemia. Kidney Int 35: 1004-1014, 1989
27. Pouteil-Noble C, Maiza H, Dijoud F, MacGregor B: Glomerular disease associated with hepatitis C virus infection in native kidneys. Nephrol Dial Transplant 15[Suppl 8]: 28-33, 2000
28. Stehman-Breen C, Alpers CE, Couser WG, Willson R, Johnson RJ: Hepatitis C virus associated membranous glomerulonephritis. Clin Nephrol 44: 141-147, 1995
29. Stehman-Breen C, Alpers CE, Fleet WP, Johnson RJ: Focal segmental glomerular sclerosis among patients infected with hepatitis C virus. Nephron 81: 37-40, 1999
30. Markowitz GS, Cheng JT, Colvin RB, Trebbin WM, D'Agati VD: Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol 9: 2244-2252, 1998
31. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ: The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 144: 705-714, 2006
32. Dienstag JL: Hepatitis C: A bitter harvest. Ann Intern Med 144: 770-771, 2006
33. McGuire BM, Julian BA, Bynon JS Jr, Cook WJ, King SJ, Curtis JJ, Accortt NA, Eckhoff DE: Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann Intern Med 144: 735-741, 2006
34. Quigg RJ: Complement and the kidney. J Immunol 171: 3319-3324, 2003
35. Smith KD, Alpers CE: Pathogenic mechanisms in membranoproliferative glomerulonephritis. Curr Opin Nephrol Hypertens 14: 396-403, 2005
36. Trendelenburg M, Fossati-Jimack L, Cortes-Hernandez J, Turnberg D, Lewis M, Izui S, Cook HT, Botto M: The role of complement in cryoglobulin-induced immune complex glomerulonephritis. J Immunol 175: 6909-6914, 2005
37. Taneda S, Segerer S, Hudkins KL, Cui Y, Wen M, Segerer M, Wener MH, Khairallah CG, Farr AG, Alpers CE: Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice. Am J Pathol 159: 2355-2369, 2001
38. Muhlfeld AS, Segerer S, Hudkins K, Carling MD, Wen M, Farr AG, Raveth JV, Alpers CE: Deletion of the fcgamma receptor IIb in thymic stromal lymphopoietin transgenic mice aggravates membranoproliferative glomerulonephritis. Am J Pathol 163: 1127-1236, 2003
39. Clynes R, Dumitru C, Ravetch JV: Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279: 1052-1054, 1998
40. Kaneko Y, Nimmerjahn F, Madaio MP, Ravetch JV: Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J Exp Med 203: 789-797, 2006
41. Muhlfeld AS, Segerer S, Hudkins K, Farr AG, Bao L, Kraus D, Holers VM, Quigg RJ, Alpers CE: Overexpression of complement inhibitor Crry does not prevent cryoglobulin-associated membranoproliferative glomerulonephritis. Kidney Int 65: 1214-1223, 2004
42. Wornle M, Schmid H, Banas B, Merkle M, Henger A, Roeder M, Blattner S, Bock E, Kretzler M, Grone HJ, Schlondorff D: Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol 168: 370-385, 2006